12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients

Clinical trial NCT00789035 · COMPLETED

Trial details

NCT number: NCT00789035
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2008-10-01
Primary completion: 2009-10-01
Enrollment: 408

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.